Outlook Therapeutics, Inc. (OTLK)
Latest OTLK Insider Trades
About Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
- ISELIN, NJ
- 17
- 2016
- XNAS
https://www.outlooktherapeutics.comSEC filings for OTLK on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 12 | 29,708,231 | $7.62M |
| Grant or award | 2 | 310,078 | |
| Other acquisition / disposition | 3 | 15,488,570 |
OTLK Insider Transactions (Form 4)
5829 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert Charles Jahr - Officer | Open-market purchase | Common Stock | 151,515 |
Recent OTLK Form 8-K Filings
5OTLK Insider Trading - FAQ
What is the latest insider trade for OTLK?
Outlook Therapeutics, Inc. (OTLK) had 8 insider filings in the last 90 days, with the most recent on 2026-08-15. The full record for OTLK runs to 29 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying OTLK stock?
12 insider purchases of OTLK were filed in the last 90 days, totaling $7.62M.
How many insiders are selling OTLK stock?
No insider sales of OTLK were filed in the last 90 days.
Where can I see OTLK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks OTLK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow OTLK insider buys?
Create a free InsiderAlpha account and press Watch on this page to add OTLK to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Robert Charles Jahr view on EDGAR
- - Ghiath M. Sukhtian view on EDGAR
- - Lawrence A. Kenyon view on EDGAR
- - Faisal Ghiath Sukhtian view on EDGAR
- - Lawrence A. Kenyon view on EDGAR
- - Robert Charles Jahr view on EDGAR
- - Yezan Munther Haddadin view on EDGAR
- - Ghiath M. Sukhtian view on EDGAR
- - Faisal Ghiath Sukhtian view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where OTLK's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track OTLK insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
